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ABSTRACT 
 
 
Denture-related stomatitis (DRS) is the most common oral disease affecting 
denture wearers today, and is characterized by inflammation of the denture bearing 
mucosa.  In a search through historical dental literature for the most often suspected 
culprit of DRS, one will repeatedly find first listed the fungus Candida albicans.  While 
C. albicans can be isolated from the fitting surfaces of dentures, and the supporting 
mucosa of patients suffering from DRS, it is also found in the oral cavity of 65% of the 
human population—most of which is free from oral disease.  A truth puzzling to 
investigators, the discovery of a self-produced, protective matrix present around colonies 
of communal bacteria and fungi (or biofilm) began to shed light on that troubling finding.   
 
Various investigators have shown that fungal cells in a biofilm community tend to 
be more resistant to anti-fungal agents than freshly grown cells. Further, it is has been 
shown that organisms thrive in a biofilm environment, and can behave differently than 
when they are out of the community.  It is not clearly understood, however, why these 
changes occur.  Regardless, C. albicans and its cell components can elicit stimulation of 
inflammatory cytokines by human monocytes, in vitro, and it is believed that this 
interaction with monocytes likely leads to the gingival inflammation evident in DRS.  
 
Post-infection therapies for DRS are known to the profession.  Prescription 
antifungal creams alone or in combination with tissue conditioning are tried-and-true 
methods of treating DRS, however, effective preventive interventions are not readily 
available.  If found, preventive therapy initiated before the onset of DRS could prevent 
the most common disease affecting denture wearers today. 
 
The current study focused on the influence of the surfactant amine oxide (AO) on 
fresh C. albicans and C. albicans cultured from biofilms, and the subsequent impact of 
that interaction on human monocyte production of IL-1β and TNF-α.  This study also 
addressed the impact that AO has on biofilm formation by examining the viability of cells 
cultured from that AO-modified matrix.  If found effective, AO may be valuable in 
preventing or reducing the incidence of DRS mediated by the fungal pathogen C. 
albicans.  Elucidating the differences between the interaction of fresh and biofilm grown 
C. albicans with human monocytes will help clarify the specific host response to this 
fungal pathogen and shed light on its effect on the chemical mediators of DRS.   
 
Currently, chemical biocides are used to control microbial growth and plaque 
accumulation on denture surfaces.  Those agents include sodium hypochlorite and various 
surfactants.  As previously mentioned, this study assessed the antifungal activity of the 
surfactant AO.  The hypotheses of this study are:  (1) AO is fungistatic and fungicidal 
against C. albicans; (2) AO will prevent or reduce fungal biofilm formation on denture 
acrylic surfaces; and (3) biofilm grown C. albicans will stimulate human monocytes to 
secrete a greater amount of inflammatory cytokines than cells derived from fresh culture. 
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Results of this study indicate a significant difference in both viability and 
monocyte stimulatory ability following exposure to AO between both fresh and biofilm-
cultured cells.  The degree of AO activity was found to be time and concentration 
dependent as higher concentrations of AO and higher exposure times to AO were found 
more effective at killing fungal cells.  Further, AO was found effective in altering some 
protective characteristic of biofilms.  The presence of the surfactant during matrix 
formation rendered inhabitant cells more subject to AO’s antifungal activity than cells 
cultured from biofilms allowed to develop outside the presence of AO. 
 
These results suggest that AO is effective at reducing the number of viable  
C. albicans cells isolated from fresh and biofilm culture, as well as fungal cells located in 
a biofilm environment.  Further, this series of experiments suggest that by reducing the 
number of viable fungal cells, AO is also capable of indirectly decreasing the activity of 
human monocytes to release the inflammatory cytokines IL-1β and TNF-α.  Future 
investigations should address the intraoral applications of AO, and its effectiveness in a 
clinical setting. 
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CHAPTER 1. INTRODUCTION 
 
 
Dr. Poul Petersen perhaps said it best in a 2005 article when he stated, “A 
demographic revolution is underway” (1).  According to studies conducted by the United 
Nations, the age group categorized as older persons (those over 60) is growing faster than 
any other age group.  It is estimated that world-wide, over 600 million people are over the 
age of 60, and it is further figured that this number will double over the next 25 years and 
more than triple in the next 50 years, reaching the billions.  Eighty-percent of those 
individuals will live in industrialized countries, with close to 100 million living in the 
U.S. by the year 2050 (1).   
 
In America, 26% of individuals 60 and older are edentulous (2).  Of this 26% of 
today’s population, many are wearing complete dentures that are not properly 
maintained.  While the suggested life span of a complete denture is between 5-7 years 
(3), literature suggests that the average denture in America is approximately 17.6 years 
old (4)!  When a denture is in service for more than 7 years, it is frequently necessary that 
it be lined to maintain adequate fit and retention.  Sadly, few seek proper care for their 
‘over-worked’ prosthesis, and as a result much soft and hard tissue irritation and 
remodeling may result, leading to what is commonly referred to as ‘denture-related 
stomatitis’ (DRS).  DRS is an inflammatory process of the mucosa that has been found to 
occur in 45-60% of the denture wearing population (5).  
 
In the absence of proper denture hygiene, an environment (or biofilm) favorable 
for the proliferation of microorganisms may develop.  A biofilm is defined as a structured 
community of microorganisms surrounded by a self-produced polymeric matrix that is 
adherent to an inert or living surface (6).  It consists of a thick layer of bacteria, yeast, 
and desquamated epithelial cells containing more than one-trillion organisms per gram in 
wet weight.  Without mechanical and/or chemical removal of this biofilm, a network of 
fungal and bacterial microorganisms may form between the intaglio surface of a 
prosthesis, and the opposing soft tissue, likely resulting in DRS (7).  C. albicans can 
usually be isolated from a biofilm on both the fitting surface of the denture and the 
denture-bearing mucosa of DRS patients (5).  
 
While in most cases a candida infection can be controlled with antifungal 
medications (either locally or systemically), control is difficult in persons with 
immunodeficiencies (e.g., HIV/AIDS) (8).  In fact, organisms may become resistant to 
standard therapy, so prevention is key.  
 
Surfactants (surface-active-agents) are used in a variety of household products as 
emulsifying agents to trap dirt, oils, bacteria, and other debris located on skin, clothes, 
dishes, and even dentures.  Surfactants are simple molecules consisting of a hydrophilic 
head (i.e., N = O) and hydrophobic tail (long carbon chain) (9).  Amine Oxide (AO; C10-
C16-alkyldimethyl N-oxides) is an example of a surfactant.  AO is an amphoteric, 
cationic surfactant.  These surfactants are not only very mild (making them useful for 
personal care and household cleaning products), but also have a disinfecting/sanitizing 
property (imparted by the cationic nature of the molecule) (9) that has recently found an 
oral application.  In a study by Fraud, et al., AO was found to be an excellent biocide for 
eliminating Streptococcus mutans biofilms from hydroxyapetite discs (10,11).  No 
research has been done on the efficacy of AO as a biocide to eliminate C. albicans from 
denture acrylic surfaces.  If found effective at reducing biofilm formation and/or its 
ability to harbor viable fungal cells, AO could promise to be a mechanism of prevention 
of DRS that currently evades the profession.   
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CHAPTER 2. REVIEW OF LITERATURE 
 
 
Polymethyl Methacrylate (PMMA) 
 
The principal type of material utilized for the fabrication of oral and maxillofacial 
prostheses is heat-activated PMMA (12).  It has remained a predictable and effective tool 
in dentistry for the past nearly seventy years namely because it is not only economical, 
but easy to use (13).  Technology is no stranger to denture acrylic, as its advancements 
have consistently improved the properties of PMMA since its inception in 1937 (13).  
However, one property not likely to be eliminated in heat-cured PMMA is the issue of 
porosity.  The polymerization of heat-processed denture acrylic is an exothermic reaction 
initiated by a heat-activated chemical element (14).  While porosity is less of an issue at 
the surface of the acrylic, the body of the material remains at risk due to boiling monomer 
within the depth of the acrylic caused by poor conduction of heat by the material itself.  
The product of this reaction is a very stable and strong material that although seemingly 
completely dense remains essentially a porous structure.   
 
 
The Complete Denture 
 
 A common prosthesis fabricated using PMMA is the complete denture.  The 
denture base derives its support through intimate contact with the underlying oral tissues 
(14), a result not easily achieved even at delivery of a new prosthesis.  Conventionally 
heat-cured, compression molded PMMA has a volumetric shrinkage of 7% and linear 
shrinkage of less than 1% on average (14).  The need of clinical and laboratory remounts 
along with adjustment of the intaglio surface of the new prosthesis evidence these minor, 
yet significant changes from the pre-processed state of the complete denture (15).  
Likened to a time capsule by some authors, a complete denture remains, over time, an 
accurate representation of the state of the denture bearing oral mucosa at the time of 
master impression in creation of the prosthesis.   
 
The lifespan of a complete denture is not clearly defined in literature due in part 
to the subjective nature of that determination, however, anecdotally, 5-7 years is an 
accepted term of many (3).  The need for a new prosthesis by the patient remains the true 
definer of the lifespan of a complete denture, and is usually a result of lack of fit, and a 
consequent decrease in function.  While that finding is expected to occur in the 5-10 year 
range, the vast majority of denture wearers are more hopeful, with the average complete 
denture in America being 17.6 years old (4).   
 
With an increase in age of an un-modified prosthesis comes a decrease in its 
stability as a result in the non-intimate contact of its intaglio surface to the underlying 
mucosa.  What is created at that point is a space sufficient for the retention of food, 
saliva, denture adhesive, and native bacteria and fungi. 
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Candida albicans 
 
Candida albicans is the most common fungus isolated from the human oral 
cavity, being found in over 65% of the population.  Introduction into the oral cavity may 
occur via many routes including kissing others whose mouths are colonized by the 
fungus, to ingesting contaminated processed and unprocessed food (16).  It is a 
polymorphic fungus consisting of a thick cell wall that preferentially colonizes mucosal 
surfaces of the GI tract.  Components of the cell wall (adhesins) mediate the binding of C. 
albicans to other cells (host or microbial), inert polymers, or proteins (16).  It is this 
adhesion that allows C. albicans to colonize the oral cavity.  Without adhesion, the yeast 
cells would be washed out by saliva and swallowed (16).  While C. albicans will grow 
more quickly and reach higher cell concentrations in moist environments (16), if the 
degree of contamination is high enough, cells can remain viable on dry surfaces for at 
least 24 hours (16,17). 
 
 
Biofilm 
 
A biofilm is a structured community of micro-organisms surrounded by a self-
produced polymeric matrix, and is adherent to an inert or living surface (5,6).  Biofilms 
may easily form on intraoral prostheses in the absence of good oral hygiene.  As a result, 
a thick biofilm of bacteria, yeast, and desquamated epithelial cells containing more than 
one-trillion organisms per gram in wet weight may quickly form.  The biofilm matrix is 
believed to alter the characteristics of its inhabitants through not only mechanical and 
chemical protection from surrounding agents, but also from intimate interaction between 
bacterial and fungal neighbors (18).  In fact, certain mechanisms of phagocytosis of 
fungal cells are ineffective when the fungus is located in this biofilm environment (19).  
Biofilms have also been found effective at increasing the antifungal resistance of fungal 
inhabitants.  Lamfon, et al. has shown that biofilms can increase the antifungal resistance 
of its fungal tenants up to one thousand times over that of planktonically grown cells 
(20).  Without mechanical and/or chemical removal of this biofilm, this network of 
fungal and bacterial microorganisms may persist on the intaglio surface of a prosthesis 
likely resulting in the type of local tissue inflammation characteristic of DRS (7). 
 
 
Denture-Related Stomatitis (DRS) 
 
A disease characterized by a lesion that is almost invariably asymptomatic and 
usually affects the hard palate, DRS is defined as an inflammatory process of the mucosa 
underlying a removable, partial, or total dental prosthesis or appliance (7).  Candida 
albicans has been associated with DRS since 1936 (21), and remains one of the most 
suspected major agents of this disease process.  While the pathogenesis of DRS is not 
fully understood, it is known that it is not an allergic reaction to C. albicans (22) that 
leads to the characteristic inflammation associated with the disease.  There are, however, 
many other theories and models of likely modes of infection.  Whether due to invasive 
forms of the fungus (23), a compromised state of the immune system (24), or alteration of 
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the typical monocyte release of inflammatory cytokines and their mediators (25), denture 
stomatitis remains a persistent problem for dentists and their edentulous patients.  What is 
consistent throughout literature is the consensus on the first step in the infection process 
of DRS: the adherence of C. albicans to oral epithelial cells.  Without that mechanism, 
the fungus would be unable to overcome the normal flushing of saliva through the oral 
cavity, and would not be able to reach an infective number of colony forming units in its 
habitat (26).  When invaded by C. albicans, oral epithelial cells are the frontline defense 
mechanism of the body, releasing large numbers of pro-inflammatory and 
immunoregulatory cytokines including IL-1β and TNF-α (27).  These cytokines are 
believed to target cell surface components of C. albicans.  While this mechanism is 
effective, various studies have shown the ability of C. albicans to modify the 
characteristics of its cell surface based on not only the temperature of its environment, 
but also the pH and nutrient content (25,28) of the oral cavity.  Other recently reported 
cell-mediated fungicidal mechanisms involve the hyaluronic acid that is bound to the 
epithelial cell wall and excreted by the cell itself (29).  The mechanism of action of 
hyaluronic acid has not been identified.   
 
The fungus maintains in its own defense not only the ability to modify its own 
cell surface characteristics (as earlier described), but also to fabricate a protective matrix 
or biofilm.  Perhaps more effective in evading host defensive mechanisms, the biofilm 
environment provides not only a physical barrier to clearance mechanisms of the oral 
cavity and host cells, but also serves as a venue for phenotypic alteration of its inhabitants 
(18,20).  Reports in literature attribute this physical barrier and eventual phenotypic 
alteration as significant contributors to DRS initiation and perpetuation as well as a 
platform to developed resistance to traditional antifungal therapies (18,20,30).  Factoring 
in the belief that poorly fitting dentures predispose to a candida infection by breaking 
down the epithelial barrier (31) of the oral cavity, the pathogenicity and astonishing 
number of individuals that experience DRS becomes less of an enigma.    
 
According to literature, 65% of current denture wearers will experience DRS at 
one point in their lifetimes, resulting in not only localized, chronic inflammation, but also 
modification of the denture bearing mucosa, thus making stability of the complete 
denture an exception, instead of a rule.  PMMA used to fabricate complete dentures 
serves as a perfect environment for colonization by bacteria and fungi.  Micro-porosity of 
the denture base combined with space present beneath an ill-fitting prosthesis 
accommodate the colonization of these surfaces by biofilms of fungi and bacteria (31).  
Large levels of colonization and tissue invasion create a situation not easily overcome by 
the traditional tissue conditioning and antifungal therapy.  Some authors propose the 
eventual use of immunomodulatory drugs to treat denture stomatitis hoping to alter the 
host response to fungus invasion (32).  However, as identified by Perezous, et al., 
treatments aimed at only the intraoral condition of the infection may result in an 
immediate decrease in inflammation, but the effect is short lived if the fungus is not 
eliminated from the denture surface as well (24).   
 
Studies of the effectiveness of surface charges on acrylic resin to inhibit fungus 
hyphae attachment are reported in recent literature (33,34,35).  Commercially available 
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denture cleaning agents have also undergone the scrutiny of recent research (36).  While 
both reports claim effective prevention of fungal cell attachment to acrylic surfaces, they 
do not address prevention or dissolution of biofilm attachment.  Also, neither group of 
studies purports a fungicidal or fungistatic mechanism to their experimental material.  As 
reported collectively in literature on DRS, there is a clear need for further investigation of 
factors that may moderate the adhesion of organisms and subsequent colonization of 
denture base materials and oral mucosa.   
 
 
Amine Oxide 
 
Surfactants (surface-active-agents) are used in a variety of household products as 
emulsifying agents to trap dirt, oils, bacteria, and other debris located on skin, clothes, 
dishes, and even dentures.  Surfactants are simple molecules consisting of a hydrophilic 
head (i.e., N=O) and hydrophobic tail (long carbon chain) (9). Discovered and studied 
before 1900 (37), amine oxide (AO; C10-C16-alkyldimethyl N-oxides) is an example of 
a surfactant.  AO is an amphoteric, cationic surfactant.  These surfactants are not only 
very mild (making them useful for personal care and household cleaning products), but 
also have a disinfecting/sanitizing property (imparted by the cationic nature of the 
molecule) (9) that has recently found an oral application. In a study by Fraud, et al., AO 
was found to be an excellent biocide for eliminating Streptococcus mutans biofilms from 
hydroxyapetite discs (10,11).  However, efforts to apply AO as a surfactant to control  
C. albicans in complete denture patients with DRS have not been investigated.   
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CHAPTER 3. RESEARCH OBJECTIVES 
 
 
DRS is an errythematous inflammatory reaction of the denture bearing mucosal 
layer of the oral cavity. Candida albicans (the most common fungal pathogen associated 
with DRS) has been shown to cause significant problems in both healthy and immuno-
compromised individuals (24).  The ability of C. albicans to colonize denture material 
and readily form biofilms imparts to the fungus a resistance to antifungal agents (18,20).  
This may constitute a significant public health problem, particularly in immuno-
compromised individuals (24).  Blocking fungal colonization and biofilm formation on 
denture base material in an effort to prevent C. albicans-mediated DRS has been 
identified as a ‘clear need’in reviews on the topic (21).  
 
Studies have shown that C. albicans and cell components elicit stimulation of 
inflammatory cytokines by human monocytes, in vitro (25,27,28). However, the 
interaction of biofilm grown C. albicans versus freshly cultured cells with human 
monocytes has not been studied.  It is possible that biofilm-grown cells differ in either 
their ability to stimulate human monocyte release of different types cytokines, different 
quantities of cytokines, or both.  
 
Studies have demonstrated that a biofilm environment evokes changes in 
microorganisms, whereby biofilm-associated organisms behave differently than freshly 
cultured cells (18,20).  Such changes have been further demonstrated by various 
investigators by studying the differences in C. albicans sensitivity to commonly used 
antifungal agents.  Determining how these changes may alter a host response to  
C. albicans may prove useful.  Thus, a comparison of the interaction of freshly-grown  
C. albicans with human monocytes to biofilm-grown C. albicans with human monocytes 
was accomplished in this project.  
 
The bacteriostatic and bactericidal activity of AO on several microorganisms has 
recently been reported (10,11).  AO has been shown to possess anti-bacterial function, 
and to reduce oral streptococcal plaque and biofilm formation. This prompted us to 
further investigate the antifungal activity of AO, and examine AO’s ability to prevent the 
formation and/or dissipation of biofilm formed on denture acrylic surfaces by  
C. albicans.  The following specific aims and hypotheses were formulated to focus this 
study. 
 
 
Specific Aim I 
 
Study the fungicidal and fungistatic properties of AO on freshly cultured and 
biofilm-grown C. albicans.  It is hypothesized that AO is fugistatic and fungicidal against 
C. albicans.     
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Specific Aim II 
 
Investigate the effect of AO on (a) the formation of C. albicans biofilm formation 
on PMMA discs and (b) Study the effect of AO on the preformed biofilm on PMMA 
discs.  It is hypothesized that AO will prevent or reduce fungal biofilm formation on 
denture acrylic surfaces. 
 
 
Specific  Aim III 
 
Investigate the interaction of freshly cultured and biofilm-grown C. albicans 
extracts with cultured monocytic THP-1 cells to secrete cytokines, IL-1β and TNF-α.  It 
is hypothesized that biofilm-grown C. albicans will be a better stimulant of monocyte 
secreted inflammatory cytokines than the freshly cultured cells. 
 
The results of this study may help clarify the pathogenic role of C. albicans in and 
out of a biofilm environment.  Results may also identify AO as a valuable agent in 
controlling DRS mediated by C. albicans. 
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CHAPTER 4. METHODS AND MATERIALS 
 
 
Amine Oxide 
 
The AO, N,N-dimethyldodecylamine N-oxide solution (C14H31NO), was obtained 
from Sigma-Aldrich Chemical Co. (St. Louis, MO).  AO was diluted to a concentration 
of 0.1% (stock) in saline and then two-fold dilutions of the AO were prepared (up to 
0.001%). 
 
 
Fungal Strains 
 
C. albicans (ATCC 44505) maintained in the UTHSC Dental Research Center 
was grown for 24 hours at 37 °C in Sabouraud-dextrose broth (SDB; Difco Laboratories) 
in an orbital water bath shaker at 60 rpm to obtain stationary-phase yeast cells.  Cells 
were harvested by centrifugation at 4 °C and washed twice with phosphate-buffered 
saline (PBS; pH 7.2).  Suspension of C. albicans were prepared by measuring the 
absorbance of the cells at 600 nm and counted under a light microscope to determine the 
number of yeast cells per milliliter. The suspension was adjusted to a concentration of 1 x 
105 colony-forming units (CFU) per milliliter, and used in experiments as a standard cell 
suspension.  The cells were examined microscopically to verify non-budding yeast phase, 
and used immediately. 
 
 
Denture Substrate Material 
 
Two-millimeter thick sheets of conventionally heat-activated polymethyl 
methacrylate (PMMA) were processed according to manufacturer’s specifications 
(Densply Trubyte, Densply International).  Sheets were cut into circular discs of 7mm in 
diameter.  The discs were stored in purified water for seven days to remove any residual 
monomer.  The discs were disinfected by dipping them in 70% alcohol for one minute, 
and washed with sterile, distilled water before experimental use.  The discs were 
routinely tested for sterility. 
 
 
Preparation of Fungal Biofilms  
 
Paraffin-stimulated whole human saliva was collected from 20 healthy volunteers 
in 50 mL sterile tubes, and was kept in a beaker of ice.  The saliva was clarified by 
centrifugation (10,000 x g; 20 minutes; 4 °C).  The samples were kept on ice during 
collection in order to avoid any enzymatic degradation.  PMMA discs were incubated 
with clarified whole human saliva for 8 hours at 37 °C.  Discs were removed and washed 
with PBS and then used in C. albicans adhesion assays and biofilm formation. 
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 Saliva-coated PMMA discs were incubated with 500 µl of standardized cell 
suspension of C. albicans (105 cells/mL) and incubated for 3 hours at 37 °C on a rocker.  
The discs were gently washed with PBS, agitated to ensure the removal of non-adherent 
cells and then transferred to a new plate.  After this adhesion phase the discs were 
immersed in SDB medium with 50mM of glucose and incubated on a rocker table for 72 
hours for biofilm formation. The number of adherent fungal cells were determined by 
XTT (sodium 3*-[1-(phenylamino-carbonyl)-3,4-tetrazolium]-bis (4-methoxy-6-nitro) 
benzene sulfonic acid hydrate; Roche Laboratories) assay. 
 
 
Antifungal Activity of Amine Oxide 
 
Freshly cultured and biofilm grown C. albicans were suspended to a stock 
concentration of 1 x 105 cells/ml. Ten-fold dilutions of the stock fungal cells were then 
made in saline. A two-fold dilution of AO was prepared (0.1% to 0.001%) in saline. 
Equal amounts (0.5 mL) of AO and C. albicans (diluted as described above) were mixed 
and incubated for 30 min at 37 °C. The viability of fungal cells after exposure to AO was 
assayed by the XTT cell proliferation method.   
 
 
XTT Cell Proliferation Assay 
 
The biofilm formation on PMMA discs was also measured by the metabolic 
reduction of XTT (sodium 3*-[1-(phenylamino-carbonyl)-3,4-tetrazolium]-bis (4-
methoxy-6-nitro) benzene sulfonic acid hydrate; Roche Laboratories) to a soluble 
formazan product by yeast cells.  The discs with biofilms were transferred to microtiter 
plates that contained 100 µl PBS per well to which 50 µl of XTT reagent (final 
concentration of XTT 0.3mg/ml) was added.  Plates were incubated at 37 °C for two 
hours.  The absorbance of the supernatant was measured at 492nm using an ELISA 
reader (Bio-Rad Laboratories). A standard curve with known number of fungal cells was 
generated which enabled the determination of viable number of fungal cells.  Fungal cells 
were then collected by scraping the PMMA discs, washed with saline and adjusted to a 
concentration of 1 x 105 cells/mL in preparation for assays. 
 
 
THP-1 Cells 
 
THP-1 cells (ATCC TIB 202) were grown in suspension in 75 cm2 plastic tissue 
culture flasks (Corning Glass Works, Corning, N.Y.) in RPMI 1640 (GIBCO, 
Gaithersburg, Md.) complete medium (CM) with addition of the antibiotics penicillin G 
sodium (100 U/ml) and streptomycin sulfate (100 μg/mL) and supplemented with 10% 
(vol/vol) heat-inactivated fetal bovine serum, and amino acids. Cells were incubated at 37 
°C in a humidified atmosphere consisting of 5% CO2. 
 
Suspensions of freshly grown and biofilm grown fungal cells (105 cells) were 
exposed to varying concentrations of AO.  The fungal cells were then subjected to mild 
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sonication, keeping the cells on ice for 60 seconds, and then centrifuged. The cell 
supernatants were collected, their protein concentration adjusted and then used in 
cytokine assays. A suspension of THP-1 cells (1x105) was incubated with extracts of 
fresh and biofilm C. albicans for 24 h at 37 °C. The culture supernatants were collected, 
centrifuged and assayed for levels of cytokines. 
 
IL-1β and TNF-α Cytokine Assay 
THP-1 cells were incubated with extracts of gently sonicated fresh and biofilm-
cultured C. albicans cells (1 x 105) for 24 hours.  Supernatant fluids of untreated THP-1 
cells and those treated with extracts of freshly grown and biofilm grown C. albicans 
(standardized to contain same amount of protein, determined by BioRad protein assay) 
were stored at −80 °C until used for measurement of IL-1β and TNF-α secretion.  
Cytokines released by THP-1 cells (when stimulated with fresh and biofilm grown 
C.albicans) were measured with commercial enzyme-linked immunosorbent assay 
(ELISA) kits (R & D Systems, Minneapolis, Minn.).  The average absorbance values for 
each triplicate set of standards, controls, and samples were calculated by using a standard 
curve. Results were expressed as picograms of IL-1β or TNF-α per milliliter of 
supernatant fluid. 
 
 
Data Analysis 
 
Each experiment was performed a minimum of three times, with triplicate 
determinations at each point.  Results were evaluated for statistical significance by 
ANOVA followed by Scheffe’s f-test.  Differences in results with a p-value less than 0.05 
were considered significant. 
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CHAPTER 5. RESULTS 
 
 
Effect of pH on Antifungal Activity of AO 
 
C. albicans (1 x 10 5 CFU/mL) from fresh and biofilm culture was treated with 
0.001% AO at various pH values (4.5 to 7.0) for 10 minutes, and then assayed for cell 
viability using the XTT method previously described.  As demonstrated in Table 1 and 
Figure 1, AO demonstrated antifungal activity within culture groups at all pH values.  
However, AO’s antifungal activity differed between culture groups, affecting fungal cells 
cultured from fresh environments more than cells cultured from biofilm environments.  
AO activity was not statistically different within culture groups, but was found 
statistically different between culture groups at p < 0.05.   
 
 
Effect of AO on Adherence of C. albicans to PMMA Discs 
 
Fresh C. albicans (1 x 105 CFU/mL) was combined with saliva-coated PMMA 
and varying concentrations of AO (0.005%, 0.001%, 0.01%), and was allowed to 
incubate for 3 hours at 37 °C.  Fungal cells adhering to the discs following the incubation 
period were assayed using the XTT method previously described.  As demonstrated in 
Table 2 and Figure 2, at increasing concentration of AO, the number of viable  
C. albicans cells decreased.  Cell viability was statistically different between all AO 
concentration groups at p < 0.05. 
 
 
Influence of AO on Salivary Pellicle Formation on PMMA Discs 
 
Fresh C. albicans (1 x 105 CFU/mL) was combined with saliva and varying 
concentrations of AO coated PMMA (0.0005% to 0.01%) that had been incubated for 8 
hours at 37 °C.  Following addition of the fungal cells, the mixture was allowed to 
incubate further for 3 hours at 37 °C.  As demonstrated in Table 3 and Figure 3, at 
increasing concentration of AO, the number of viable C. albicans cells decreased.  Cell 
viability was statistically different between all AO concentration groups at p < 0.05. 
 
 
Effect of AO Exposure Time on Viability of C. albicans  
 
C. albicans (1 x 105 CFU/mL) from fresh and biofilm cultures was treated with 
0.001% AO for varying periods of time (5 minutes to 60 minutes), and then assayed at 
each time period for cell viability using the XTT method previously described.  As 
demonstrated in Table 4 and Figure 4, at increasing exposure time to AO, the number of 
viable C. albicans cells decreased in both fresh and biofilm groups.  However, a greater 
number of viable cells from biofilm culture persisted in exposure times (20 minutes to 30 
minutes) in which fresh cells could not survive.  Cell viability was statistically different  
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Table 1.  Effect of pH on Antifungal Activity of AO. 
 
Source pH 4.5 pH 5.0 pH 5.5 pH 6.0 pH 7.0 
Fresh 360 ± 40 470 ± 20 540 ± 60 490 ± 40 410 ± 30 
Biofilm 870 ± 30 1120 ± 60 1070 ± 30 1210 ± 20 980 ±40 
 
 
 
 
4.5 5.0 5.5 6.0 7.0
0
200
400
600
800
1000
1200
1400
N
um
be
r o
f V
ia
bl
e 
C
el
ls
pH Value
Fresh Cells
Biofilm Cells
 
 
Figure 1.  Effect of pH on Antifungal Activity of AO. 
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Table 2.  Effect of AO on Adherence of C. albicans to PMMA Discs. 
 
Concentration of AO # of Cells 
0 97500 ± 3200 
0.0005% 3150 ± 280 
0.001% 960 ± 80 
0.01% 0 
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Figure 2.  Effect of AO on Adherence of C. albicans to PMMA Discs. 
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Table 3.  Influence of AO on Salivary Pellicle Formation on PMMA Discs. 
 
Concentration of AO # of Cells 
0 95000 ± 3250 
0.0005% 7800 ± 350 
0.001% 600 ± 300 
0.01% 150 ± 40 
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Figure 3.  Influence of AO on Salivary Pellicle Formation on PMMA Discs. 
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Table 4.  Effect of AO Exposure Time on Viability of C. albicans. 
 
Exposure Time # Cells—Fresh # Cells—Biofilm   
0 minutes 96500 93000 ± 2600 
5 minutes 980 12500 ± 1150 
10 minutes 460 1050 ± 90 
15 minutes 120 820 ± 60 
20 minutes 0 440 ± 50 
30 minutes 0 160 ± 30 
45 minutes 0 0 
60 minutes 0 0 
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Figure 4.  Effect of AO Exposure Time on Viability of C. albicans.
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between culture groups at all exposure times, and was also statistically different within 
culture groups up to 20 minutes and 45 minutes for fresh and biofilm culture groups, 
respectively (p < 0.05).   
 
 
Effect of AO on Fresh and Biofilm-Cultured C. albicans 
 
C. albicans (1 x 105 CFU/mL) from fresh and biofilm cultures was treated with 
varying concentrations of AO (0.0001% to 0.01%) for 10 minutes, and then assayed for 
cell viability using the XTT method previously described.  As demonstrated in Table 5 
and Figure 5, at increasing concentration of AO, the number of viable C. albicans 
cells/mL decreased in both fresh and biofilm groups.  However, a greater number of 
viable cells from biofilm culture persisted in levels of AO concentration (0.005% to 
0.1%) in which fresh cells could not survive.  At AO concentrations of 0.0001% and 
higher, cell viability was statistically different between and within both culture groups at 
p < 0.05. 
 
 
Effect of AO on Biofilm Formation on PMMA Discs 
 
Fresh C. albicans (1 x 105 CFU/mL) was combined with saliva-coated PMMA 
and allowed to incubate for 3 hours at 37 °C.  Varying concentrations of AO (0.0001% to 
0.005%) were then added to this environment for 10 minutes.  Cells located in the biofilm 
were sampled and assayed for cell viability using the XTT method previously described.  
As demonstrated in Table 6 and Figure 6, at increasing concentration of AO, the number 
of viable cells/mL decreased.  Cell viability was statistically different between all AO 
concentration groups at p < 0.05. 
 
 
Effect of AO on IL-1β Secretion by THP-1 Cells 
 
C. albicans (1 x 105 CFU/mL) from fresh and biofilm culture was exposed to 
increasing concentrations of AO (0.0001% to 0.005%) for 10 minutes and then separately 
pelleted and gently sonicated to obtain cell extracts  The cell extract (100µL of mg/mL 
stock) was used in the assay to stimulate THP-1 cells.  The level of IL-1β secretion was 
assayed using the ELISA method previously described.  As demonstrated in Table 7 and 
Figure 7, at increasing concentration of AO, the level of IL-1β stimulation decreased.  
Further, a lower level of cytokine stimulation resulted from exposure to fresh culture cells 
than from biofilm culture cells.  While the level of IL-1β stimulation at different AO 
concentrations was statistically different within each culture group (p < 0.05), the level of 
stimulation was only statistically different between culture groups at AO concentration of 
0.0001% (p < 0.05). 
 
Table 5.  Effect of AO on Fresh and Biofilm-Cultured C. albicans. 
 
Concentration of AO # Cells—Fresh  # Cells—Biofilm  
0 95000 ± 3500 93500 ± 1200 
0.0001% 31000 ± 1250 75000 ± 3500 
0.0005% 1650 ± 200 4200 ± 450 
0.001% 480 ± 50 950 ± 40 
0.005% 0  400 ± 80 
0.01% 0  120 ± 60 
0.1% 0  0 
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Figure 5.  Effect of AO on Fresh and Biofilm-Cultured C. albicans. 
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Table 6.  Effect of AO on Biofilm Formation on PMMA Discs. 
 
Concentration of AO # of Cells 
0 94300 ± 2900 
0.0001% 37700 ± 800 
0.0005% 2650 ± 380 
0.001% 670 ± 40 
0.005% 0 
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Figure 6.  Effect of AO on Biofilm Formation on PMMA Discs. 
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Table 7.  Effect of AO on IL-1β Secretion by THP-1 Cells. 
 
Concentration of AO IL-1β Stimulated by Fresh 
Cells (pg/mL) 
IL-1β Stimulated by 
Biofilm Cells (pg/mL) 
0 270 ± 24 346 ± 21 
0.0001% 126 ± 18 178 ± 23 
0.0005% 74 ± 9 89 ± 14 
0.001% 23 ± 5 36 ± 9 
0.005% 12 ± 3 19 ± 6 
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Figure 7.  Effect of AO on IL-1β Secretion by THP-1 Cells. 
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Effect of AO on TNF-α Secretion by THP-1 Cells 
 
C. albicans (1 x 105 CFU/mL) from fresh and biofilm cultures was exposed to 
varying concentrations of AO (0.0001% to 0.005%) for 10 minutes and then separately 
pelleted and gently sonicated to obtain cell extracts.  The cell extract (100µL of mg/mL 
stock) was used in the assay to stimulate THP-1 cells.  The level of TNF-α secretion was 
assayed using the ELISA method previously described.  As demonstrated in Table 8 and 
Figure 8, at increasing concentration of AO, the level of TNF-α stimulation decreased.  
Further, the level of cytokine stimulation was lower for fresh culture cells than for 
biofilm culture cells.  TNF-α activity was statistically different between and within 
culture groups at each AO concentration level at p < 0.05.   
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Table 8.  Effect of AO on TNF-α Secretion by THP-1 Cells. 
 
Concentration of AO TNF-α  Stimulated by 
Fresh Cells (pg/mL) 
TNF-α  Stimulated by 
Biofilm Cells (pg/mL) 
0 390 ± 41 546 ± 38 
0.0001% 286 ± 22 338 ± 44 
0.0005% 114 ±9  159 ± 21 
0.001% 43 ± 8 76 ± 12 
0.005% 19 ± 5 29 ± 6 
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Figure 8.  Effect of AO on TNF-α Secretion by THP-1 Cells. 
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CHAPTER 6. DISCUSSION 
 
 
Effect of pH on Antifungal Activity of AO 
 
The pH of human saliva may vary in several circumstances, including time of 
day, proximity to meals, quantity and quality of saliva, type of diet, and state of oral 
health (38).  Of particular interest in this study is how a change in oral health evident in 
DRS (which is known to lower the pH of the oral cavity) could effect the anti-fungal 
activity of AO.  Saliva collected from 20 healthy volunteers was pooled, and used 
throughout the experimental procedure, and was found to have a pH of 6.5.  Modification 
of the pH of saliva samples separated from the pooled volume was accomplished by 
acid/base additions.  Results of this study show that a 0.0001% AO concentration when 
exposed to fresh and biofilm-cultured C. albicans cells for a period of 10 minutes is not 
significantly affected in its antifungal ability.  Therefore, pH does not appear to alter the 
effect that AO has on fungal cells derived from within and outside of a biofilm 
environment.   
 
 
Effect of AO on Adherence of C. albicans to PMMA Discs 
 
An objective of tissue conditioning in DRS patients is prevention of further 
disease concomitant with resolution of existing infection.  Typical clinical procedures 
involve thorough cleaning of the denture base material utilizing a 2.6% sodium 
hypochlorite solution following removal of lining materials and preceding their 
replacement (39).  The cidal activity of this procedure is directly aimed at the fungal and 
bacterial components of denture bases of DRS patients’ prostheses.  While caustic to 
fungal and bacterial pathogens, sodium hypochlorite is also very abusive to intraoral 
tissues and may affect denture base chromaticity when not rinsed completely following 
application.  Fraud, et al. has stated in previous projects that low concentrations of AO 
are safe for intraoral tissues, and even safe for intraoral use and application (10,11).   
 
In this experimental procedure, the attempt to form a biofilm on PMMA in the 
presence of varying amounts of AO yielded decreasing numbers of viable cells scraped 
from the PMMA discs as AO concentration was increased. This result suggests that AO 
is perhaps capable of either attacking and destroying fungal cells before they are able to 
form the biofilm matrix, or more likely (given the presence of a biofilm on the PMMA 
discs even at high AO concentrations) that AO is somehow thwarting the protective 
characteristics of biofilms as they are formed by merely being incorporated into the 
matrix as it develops.  Further study into this mechanism of action is warranted. 
 
 
Influence of AO on Salivary Pellicle Formation on PMMA Discs 
 
DRS patients are instructed to follow a strict and time consuming protocol for 
home care of their prosthesis in an effort to maintain the level of cleanliness between 
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clinical visits.  Even the most meticulous home care may not address and prevent the 
recurrence of fungal, bacterial, and resultant biofilm reformation in hard to reach areas of 
the prosthesis (39).  Impossible to reach by any method of home care are the porous 
portions of the denture (the base and overlying tissue conditioner lining material).  
Because of the presence and physical characteristics of the lining material, home use of 
sodium hypochlorite is not recommended, as incomplete removal of the hypochlorite 
solution following application could exacerbate the soft tissue inflammation the clinician 
and patient are striving to control.   
 
 In this experimental procedure, varying levels of AO were allowed to remain in 
contact with PMMA discs in the presence of saliva for an 8 hour period of time prior to 
introduction of fungal cells.  As AO concentration increased, the number of viable cells 
remaining in biofilm culture following a three hour incubation period decreased.  These 
results suggest that AO (when contact with PMMA is maintained for 8 hours) decreases 
the number of viable C. albicans cells able to attach to PMMA.  AO may function by 
decreasing the number of cells capable of producing the biofilm, by weakening the matrix 
itself as it is incorporated into the structure during development and maturation, or by 
decreasing the adherence of saliva molecules to the PMMA which indirectly prevents 
biofilm attachment.  In any case, the results are interesting, and even the suggestion that 
AO could modify the protective characteristic of biofilm environments warrants further 
investigation into the matter.     
 
 
Effect of AO Exposure Time on Viability of C. albicans 
 
 A concern of any treatment modality, regardless of the condition being addressed, 
is patient compliance.  The year 2009 has brought many advancements in technology that 
have ‘streamlined’ human existence.  Anecdotally, clinicians find that patient patience 
and devotion to their prescribed care can sometimes fall short of expectation usually due 
to the lack of devoted time.  Treatment of DRS is often extremely frustrating for 
clinicians as resolution of infection may take weeks to months of costly and frequent 
clinical visits.  While prescription of antifungal creams, troches, and systemic 
medications have hastened the process of DRS treatment, it can remain painfully slow in 
severe cases of the condition, particularly in non-compliant patients.  The need for an 
effective, easy, and efficient method to address DRS is greater than ever, particularly as 
populations of the denture wearing community increase anually.   
 
 In this experimental procedure, a 0.001% AO concentration was exposed to  
C. albicans cells derived from fresh culture and derived from biofilm culture for a 
varying period of time.  As exposure time increased, the number of viable cells remaining 
in each culture source decreased, with biofilm-cultured C. albicans being more resistant 
to AO than those from fresh culture, requiring 45 minutes for complete destruction of all 
remaining cells.  These results suggest that even at very low concentration of AO, 
increasing the exposure time to the different cultures will eventually result in complete 
destruction of any and all C. albicans cells derived from within and outside of a biofilm 
environment.  These results further suggest that AO possesses an effective and efficient 
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mechanism of action, and that with a small increase in time, even low concentrations of 
the surfactant maintains its fungicidal effect. 
 
 
Effect of AO on Fresh and Biofilm-Cultured C. albicans  
 
It is known that biofilm enviroments can evoke changes in the cells that inhabit 
portions of its matrix—possibly by mechanical protection from host and antifungal 
agents or even phenotypic alteration of the fungal cell itself (18,20).  Regardless of the 
mechanism, there is no doubt that a difference exists between cells before they become 
encased in a biofilm and after they become encased in a biofilm.  The question at this 
point for researchers and clinicians alike is how can one circumvent the protective 
features of that self-formed polymeric matrix, the biofilm.   
 
 In this experimental procedure, C. albicans cultured from both fresh and biofilm 
environments were exposed to increasing concentrations of AO for 10 minutes, and were 
then cultured for cell viability using the XTT method.  As the concentration of AO was 
increased, the number of viable cells in both groups decreased, with the biofilm-cultured 
cells being more resistant to the fungicidal effect of AO.   These results suggest that 
although the protective properties of the once present biofilm persist in the biofilm-
cultured cells when exposed to AO, AO becomes effective against biofilm cells at higher 
concentrations; the highest concentration tested in this case being 0.05% less than the 
concentration safe for intraoral use (0.06%) identified by Fraud, et al. (10,11).  This 
series of experiments again suggest that AO possesses an effective and efficient 
mechanism of action that, with an increase in concentration, can produce a fungicidal 
effect to both fresh and biofilm-cultured fungal cells. 
 
 
Effect of AO on Biofilm Formation on PMMA Discs 
 
Perhaps the most clinically relevant procedure in this series of experiments 
investigated the effect that AO has on biofilm cells embedded in the protective matrix 
located on PMMA surfaces.  This approach addressed the clinical manifestation and 
challenges encountered in private practices and institutional dental settings worldwide.  
To this point, AO has been introduced at either critical periods of biofilm development 
(namely initiation) or following physical removal of cells from a biofilm environment.  
The former attempting to discover AO’s effect on formation of the polymeric matrix and 
subsequent resistance of fungal cells to AO’s established antifungal activity, and the 
latter attempting to elucidate the change in response to AO between a freshly cultured 
cell and a cell allowed to live and mature in a biofilm environment.   
 
In this experimental procedure, PMMA discs were combined with fungal cells, 
saliva, and supportive medium, and allowed to develop a biofilm matrix, undisturbed for 
a 3 hour period of time.  Following that period of incubation, varying concentrations of 
AO were added to this medium for 10 minutes.  Following that exposure time, the 
PMMA discs were scraped, and fungal cells were isolated from the biofilm environment 
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in a method previously described, and were assayed for cell viability by the XTT method 
also previously described.   
 
These results suggest that AO is effective at killing cells as they are located within 
a biofilm environment, particularly at higher concentrations of AO.  Perhaps AO posseses 
the ability to bypass the protective characteristics of the biofilm matrix.   
 
 
Effect of AO on IL-1β Secretion by THP-1 Cells 
 
The clinical manifestation of DRS is reliant upon inflammation mediated by 
human monocyte release of inflammatory cytokines.  The established effectiveness of 
AO at decreasing the number of viable fresh and biofilm-cultured C. albicans while they 
are located in and after they are separated from biofilm environments, means little if the 
agents of the inflammatory process are not affected by AO’s activity.   
 
 In this experimental procedure, C. albicans cells cultured from fresh and biofilm 
environments were exposed to varying concentrations of AO for 10 minutes, and then 
exposed to human monocytes in a process and method previously described.  The amount 
of IL-1β (expressed in pg/mL) was assayed using the ELISA method previously 
described.  As the concentration of AO was increased, the amount of IL-1β released by 
exposed THP-1 cells decreased.  These results suggest that AO effectively reduces the 
number of viable C. albicans cells to the point that it indirectly decreases THP-1 cell 
activity in terms of IL-1β release. 
 
 
Effect of AO on TNF-α Secretion by THP-1 Cells 
 
In this experimental procedure, C. albicans cells cultured from fresh and biofilm 
environments were exposed to varying concentrations of AO for 10 minutes, and then 
exposed to human monocytes in a process and method previously described.  The amount 
of TNF-α (expressed in pg/mL) was assayed using the ELISA method previously 
described.  As the concentration of AO was increased, the amount of TNF-α released by 
exposed THP-1 cells decreased.  These results suggest that AO effectively reduces the 
number of viable C. albicans cells to the point that it indirectly decreases THP-1 cell 
activity in terms of TNF-α release. 
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CHAPTER 7. CONCLUSION 
 
 
Within the limitations of this study, results suggest that AO is effective at 
reducing the number of viable C. albicans cells isolated from fresh and biofilm culture, as 
well as fungal cells as they are located in a biofilm environment.  Further, this series of 
experiments also suggest that by reducing the number of viable fungal cells, AO is also 
capable of indirectly decreasing the activity of human monocytes to release the 
inflammatory cytokines IL-1β and TNF-α.  Future investigations should address the 
intraoral applications of AO, and its effectiveness in a clinical setting. 
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